Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Aug 2025 · 1 min read
In brief
In brief
Multi-center study demonstrates that ERAS protocols in pediatric neuroblastoma resection reduce hospital stay from 6.9 to 3.7 days and decrease complication rates from 96% to 39%. The pathway also significantly reduced opioid consumption and enabled earlier diet advancement and ambulation compared to traditional care.
Written by the GCMD Library team from the article.
Statements in this article
Enhanced recovery after surgery (ERAS) pathways are multidisciplinary strategies to return patients to their physiologic baseline as efficiently as possible.
A standardized ERAS protocol was utilized at all three participating institutions for children greater than 1 month old undergoing resection of abdominal neuroblastoma.
Post-operative nasogastric tube use decreased from 91.7% in the pre-ERAS cohort to 16.7% in the ERAS cohort.
ERAS patients were advanced to regular diets 3 days earlier than pre-ERAS patients.
ERAS patients ambulated 3 days earlier than pre-ERAS patients.
Post-operative opioid consumption decreased from 0.54 to 0.21 milligram morphine equivalents (MME) mg/kg/day with ERAS implementation (p = 0.047).
All but one patient (96%) in the pre-ERAS cohort experienced at least one post-operative complication, compared to only 39.1% in the ERAS cohort (p < 0.001).
Average length of stay was 3.7 days with ERAS compared to 6.9 days pre-ERAS (p = 0.004).
ERAS is associated with improvements in length of stay and a decrease in complications following resection of abdominal neuroblastoma.
